Evidence map›Paper›PMID 37791673›Full record

ArticleArhiv za higijenu rada i toksikologiju2023

Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer.

Suzana Žunec, Irena Brčić Karačonji, Martin Čatalinac, Andreja Jurič, Anja Katić, Goran Kozina, Vedran Micek, Marijana Neuberg, Ana Lucić Vrdoljak

Open access · diamondAbstract read
In one paragraph

Article in Arhiv za higijenu rada i toksikologiju, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Suzana Žunec1Institute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-7710-8250
Irena Brčić Karačonji1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Martin Čatalinac2University of Zagreb Faculty of Science, Zagreb, Croatia.
Andreja Jurič1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Anja Katić1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Goran Kozina3University North, University Centre Varaždin, Varaždin, Croatia.
Vedran Micek1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Marijana Neuberg3University North, University Centre Varaždin, Varaždin, Croatia.
Ana Lucić Vrdoljak1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Institute for Medical Research and Occupational Health · HRUniversity North · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical treatment with the antineoplastic drug irinotecan (IRI) is often hindered by side effects that significantly reduce the quality of life of treated patients. Due to the growing public support for products with Δ

Indexed as

Colonic NeoplasmsQuality of LifeAnimalsBiomarkersDronabinolHumansIrinotecanMaleMiceBiomarkersDronabinolIrinotecanantitumorsko djelovanjeantitumour activitycannabinoid-based preparationsoksidacijski stresoxidative stresspripravci na bazi kanabinoidasistemska toksičnostsystemic toxicity

Identifiers

PMID37791673
PMCPMC10549892
OpenAlexW4387326095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.